BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20537145)

  • 1. Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS).
    Schuster J; Karlsson T; Karlström PO; Poromaa IS; Dahl N
    Reprod Biol Endocrinol; 2010 Jun; 8():58. PubMed ID: 20537145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of PGRMC1 in patients with polycystic ovary syndrome and its molecular mechanism for regulating ovarian granulosa cell apoptosis and glucolipid metabolism.
    Zhou J; Chen Z; Li J; Deng Q; Peng X; Li L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 48(4):538-549. PubMed ID: 37385616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure.
    Mansouri MR; Schuster J; Badhai J; Stattin EL; Lösel R; Wehling M; Carlsson B; Hovatta O; Karlström PO; Golovleva I; Toniolo D; Bione S; Peluso J; Dahl N
    Hum Mol Genet; 2008 Dec; 17(23):3776-83. PubMed ID: 18782852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANP promotes proliferation and inhibits apoptosis of ovarian granulosa cells by NPRA/PGRMC1/EGFR complex and improves ovary functions of PCOS rats.
    Zheng Q; Li Y; Zhang D; Cui X; Dai K; Yang Y; Liu S; Tan J; Yan Q
    Cell Death Dis; 2017 Oct; 8(10):e3145. PubMed ID: 29072679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome.
    Conway GS; Conway E; Walker C; Hoppner W; Gromoll J; Simoni M
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):97-9. PubMed ID: 10468971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure.
    Chen J; Zhou Q; Zhang Y; Tan W; Gao H; Zhou L; Xiao S; Gao J; Li J; Zhu Z
    Bioengineered; 2021 Dec; 12(1):8778-8792. PubMed ID: 34696698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Serum A Disintegrin and Metalloproteinase with Thrombospondin Motifs-19 Levels in Different Fertility Situations: Could It Be a Serum Marker of Ovarian Function and Oocyte Pool?
    Ersoy E; Özler S; Öztaş E; Ersoy AÖ; Ergin M; Tokmak A; Yilmaz N
    Gynecol Obstet Invest; 2019; 84(1):6-11. PubMed ID: 29982260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatiotemporal expression pattern of Progesterone Receptor Component (PGRMC) 1 in endometrium from patients with or without endometriosis or adenomyosis.
    Thieffry C; Van Wynendaele M; Samain L; Tyteca D; Pierreux C; Marbaix E; Henriet P
    J Steroid Biochem Mol Biol; 2022 Oct; 223():106153. PubMed ID: 35835350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients.
    Tedesco S; Adorni MP; Ronda N; Cappellari R; Mioni R; Barbot M; Pinelli S; Plebani M; Bolego C; Scaroni C; Bernini F; Fadini GP; Cignarella A
    Endocrine; 2019 Nov; 66(2):360-369. PubMed ID: 30993600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of progesterone receptor membrane component 1 mutation in Han Chinese women with premature ovarian failure.
    Wang JL; Li SL; Qin YY; Chen ZJ
    Reprod Biomed Online; 2014 Nov; 29(5):640-3. PubMed ID: 25246111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone Receptors and Proliferation of the Endometrium in Obese Women With Polycystic Ovary Syndrome-A Lifestyle Intervention Study.
    Paulson M; Sahlin L; Hirschberg AL
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1244-1253. PubMed ID: 28388727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid promotes the expression of progesterone receptor membrane component 1 via epigenetic silencing of miR-139-5p in human and rat granulosa cells.
    Zhao G; Zhou X; Fang T; Hou Y; Hu Y
    Biol Reprod; 2014 Nov; 91(5):116. PubMed ID: 25232020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.
    Sova H; Morin-Papunen L; Puistola U; Karihtala P
    Fertil Steril; 2010 Dec; 94(7):2670-3. PubMed ID: 20430377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic expression of PGRMC1 and SERBP1 in human endometrium: an implication in the human decidualization process.
    Salsano S; Quiñonero A; Pérez S; Garrido Gómez T; Simón C; Dominguez F
    Fertil Steril; 2017 Nov; 108(5):832-842.e1. PubMed ID: 28911927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
    Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
    Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of fatty acid amide hydrolase in women with polycystic ovary syndrome.
    Cui N; Yang Y; Xu Y; Zhang J; Jiang L; Hao G
    Gynecol Endocrinol; 2017 May; 33(5):368-372. PubMed ID: 28132572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics.
    Cai G; Yang X; Ruan X; Wang J; Fang Y; Wei Y; Zhang Y; Gu M; Mueck AO
    Maturitas; 2020 Oct; 140():64-71. PubMed ID: 32972637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers.
    Ruan X; Cai G; Wei Y; Gu M; Zhang Y; Zhao Y; Mueck AO
    Menopause; 2020 Feb; 27(2):183-193. PubMed ID: 31876619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.